DrugPatentWatch Database Preview

PINDOLOL Drug Profile

« Back to Dashboard

When do Pindolol patents expire, and when can generic versions of Pindolol launch?

Pindolol is a drug marketed by G And W Labs Inc, Idt Australia Ltd, Mylan Pharms Inc, Nostrum Labs, Nostrum Labs Inc, Purepac Pharm, Sun Pharm Industries, Watson Labs, and Zydus Pharms Usa Inc. and is included in thirteen NDAs.

The generic ingredient in PINDOLOL is pindolol. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pindolol profile page.

Summary for PINDOLOL

US Patents:	0
Applicants:	9
NDAs:	13
Suppliers / Packagers:	7
Bulk Api Vendors:	48
Clinical Trials:	11
Patent Applications:	4,084
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	PINDOLOL at DailyMed

Pharmacology for PINDOLOL

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for PINDOLOL

Adrenergic beta-Antagonists

Antihypertensive Agents

Serotonin Antagonists

Vasodilator Agents

Synonyms for PINDOLOL

(.+/-.)-Pindolol

(+-)-4-(2-hydroxy-3-(isopropylamino)propoxy)indole

(+-)-lb46

(+-)-Pindolol

(1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol

(R,S)-PINDOLOL

(rs)-pindolol

[2-hydroxy-3-(1H-indol-4-yloxy)propyl](propan-2-yl)amine

1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol

1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol

1-(1h-indol-4-yloxy)-3-((1-methylethyl)amino)-2-propano

1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol

1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol

1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol #

1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol

1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol

1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol

1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol

1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol

1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol

1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol

1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol)

1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol)

1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol

1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol

1-[1H-INDOL-4-YLOXY]-3-[ISOPROPYLAMINO]-2-PROPANOL

13523-86-9

2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-

2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-

2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-

2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-

2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-

2-PROPANOL,1-(1H-INDOL-4-YLOXY)-3-[(1-METHYLETHYL)AMINO]-,()-

21870-06-4

3-indol-4-yloxy-1-[(methylethyl)amino]propan-2-ol

4-(2-Hydroxy-3-isopropylaminopropoxy)-indole

4-(3-(Isopropylamino)-2-hydroxypropoxy)indole

5-21-03-00017 (Beilstein Handbook Reference)

523P869

AB00052072

AB00052072_12

AB00052072_13

AB00052072-11

AC1L1J1N

AC1Q1QC1

AKOS015969756

AN-18448

API0000920

BDBM50019443

Betapindol

Betapindol (TN)

BG0392

Bio-0642

Blockin L

Blockin L (TN)

Blocklin

Blocklin L

Blocklin L (TN)

Blocklin-L

Blocklin-L (TN)

BPBio1_000022

BRD-A97701745-001-05-3

BRN 1536506

BSPBio_000020

BSPBio_002193

C-15218

C07445

Calvisken

Calvisken (TN)

Carvisken

Carvisken (TN)

CAS-13523-86-9

CC-33796

CCG-39223

CCRIS 9215

CHEBI:8214

CHEMBL500

CPD000059120

CS-4473

CTK8G2432

D00513

D0F2PO

DB00960

Decreten

Decreten (TN)

DivK1c_000837

DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole

DL-LB 46

DL-Pindolol

DSSTox_CID_3476

DSSTox_GSID_23476

DSSTox_RID_77043

DTXSID8023476

Durapindol

Durapindol (TN)

EINECS 236-867-9

EINECS 244-623-8

EU-0100955

FT-0630406

Glauco-visken

Glauco-Visken (TN)

Glauco-Viskin

GTPL91

HE052912

HE115935

HE299989

HE307748

HMS1568A22

HMS1920H16

HMS2089I21

HMS2091P20

HMS2095A22

HMS3259I07

HMS3262P12

HMS3267K17

HMS3369E14

HMS502J19

HSDB 6539

HY-B0982

IDI1_000837

JZQKKSLKJUAGIC-UHFFFAOYSA-N

KBio1_000837

KBio2_001589

KBio2_004157

KBio2_006725

KBio3_001693

KBioGR_000958

KBioSS_001589

L000006

LB 46

LB-46

LB46

Lopac0_000955

LP00955

LS-122385

MCULE-7764948919

MFCD00010530

MLS000069496

MLS002548891

MolPort-001-792-503

NC00467

NCGC00015786-06

NCGC00015786-07

NCGC00015786-08

NCGC00015786-09

NCGC00015786-10

NCGC00015786-11

NCGC00015786-13

NCGC00015786-14

NCGC00015786-16

NCGC00024925-03

NCGC00024925-04

NCGC00024925-05

NCGC00024925-06

NCGC00024925-07

NCGC00261640-01

NINDS_000837

NSC-757276

NSC757276

Oprea1_770884

P 0778

P-6820

PDSP1_000771

PDSP1_000772

PDSP2_000759

PDSP2_000760

Pectobloc

Pectobloc (TN)

Pharmakon1600-01500488

Pinbetol

Pinbetol (TN)

Pindolol (JP15/USP/INN)

Pindolol (JP17/USP/INN)

Pindolol [USAN:INN:BAN:JAN]

Pindolol [USAN:USP:INN:BAN:JAN]

Pindolol, >=98% (TLC), powder

Pindolol, European Pharmacopoeia (EP) Reference Standard

Pindolol, United States Pharmacopeia (USP) Reference Standard

PINDOLOL,(-)

Pindololum

Pindololum [INN-Latin]

Prestwick_397

Prestwick0_000090

Prestwick1_000090

Prestwick2_000090

Prestwick3_000090

Prindolol

Prindolol (TN)

Prinodolol

Pynastin

Pynastin (TN)

SAM002264631

SBI-0050929.P004

SC-25688

SCHEMBL5219

SMR000059120

SPBio_001289

SPBio_001959

Spectrum_001109

SPECTRUM1500488

Spectrum2_001285

Spectrum3_000547

Spectrum4_000479

Spectrum5_001266

SR-01000000027

SR-01000000027-2

ST50319990

Tox21_110221

Tox21_110221_1

Tox21_500955

Visken

Visken (TN)

Z3376

US Patents and Regulatory Information for PINDOLOL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
G And W Labs Inc	PINDOLOL	pindolol	TABLET;ORAL	073661-001	Oct 31, 1993		DISCN	No	No
Purepac Pharm	PINDOLOL	pindolol	TABLET;ORAL	074125-002	Apr 28, 1993		DISCN	No	No
Zydus Pharms Usa Inc	PINDOLOL	pindolol	TABLET;ORAL	209866-002	Aug 18, 2017	AB	RX	No	No
Idt Australia Ltd	PINDOLOL	pindolol	TABLET;ORAL	073609-002	Mar 29, 1993	AB	RX	No	No